The Iraqi Board for Medical Specializations
  • Register
  • Login

Iraqi Postgraduate Medical Journal

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 18, Issue 1
  3. Authors

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Advisory Board

Editorial Staff

Publication Ethics

Indexing and Abstracting

News

Results of Minimal Dosage Propranolol in the Management of Infantile Haemangioma

    Ahmed Ibraheim Ismaeel Zakaria A. Aarajy Nuas Hasab Jaafar Ahmed Khalaf Jasim

Iraqi Postgraduate Medical Journal, 2019, Volume 18, Issue 1, Pages 10-17

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

ABSTRACT:
BACKGROUND:
Infantile haemangioma one of the most common tumour of new borns , a safe and effective treatment
options are under ongoing research .
OBJECTIVE:
The authors show the effectiveness and safety of low dose propranolol as a method for infantile
haemangioma treatment .
METHOD:
In this study twenty- four patients with infantile haemangioma in different anatomical locations were
treated with oral propranolol and the result were assessed in a retrospective analysis of the results
patients were kept on 0.25 mg/kg/day for one month , then on 0.5mg/kg/day in 2 divided doses for
another one month , in the third month the dose will be increased to 1 mg/kg/day in 2 divided doses ,
then the propranolol were given in a maintenance dose ranging between 1-1.5 mg/kg/day in 2 divided
doses according to the clinical response .The duration of treatment ranging from 6-18 months as a
small dose increasing over a long time .
RESULTS:
We had achieved excellent result in most of our patients, with reduction of size and fade of color of
hemangioma within 1 month from the initiation of treatment, when we stop the treatment no relapses
were noticed during our follow up period after finishing the course.
CONCLUSION:
Propranolol is one of the safest and most effective treatment options for the infantile haemangioma
even in low dose, with lower relapse rates and minimal consecutive side effects and drawbacks.
Keywords:
    KEYWORDS infantile haemangioma
  • PDF
  • XML
(2019). Results of Minimal Dosage Propranolol in the Management of Infantile Haemangioma. Iraqi Postgraduate Medical Journal, 18(1), 10-17.
Ahmed Ibraheim Ismaeel ; Zakaria A. Aarajy ; Nuas Hasab Jaafar ; Ahmed Khalaf Jasim . "Results of Minimal Dosage Propranolol in the Management of Infantile Haemangioma". Iraqi Postgraduate Medical Journal, 18, 1, 2019, 10-17.
(2019). 'Results of Minimal Dosage Propranolol in the Management of Infantile Haemangioma', Iraqi Postgraduate Medical Journal, 18(1), pp. 10-17.
Results of Minimal Dosage Propranolol in the Management of Infantile Haemangioma. Iraqi Postgraduate Medical Journal, 2019; 18(1): 10-17.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 184
  • PDF Download: 160
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus